Project Farma will be in attendance at this year’s ISPE Facilities of the Future conference, January 29-30, in San Francisco, CA where we will witness exciting technical presentations, case-studies, and panel discussions from industry and regulatory leaders involved in the planning, building, and approving of the “facilities of the future”.
The 2024 ISPE Facilities of the Future Conference brings together pharmaceutical industry stakeholders, particularly those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.
This conference will explore innovations in facility design and delivery, emerging trends in technologies, manufacturing, and support areas such as laboratories and warehousing. Also included are the ways technology and digital transformation will impact the workforce of the future, and sustainability efforts in both new and legacy pharmaceutical facilities.
Conference: ISPE Facilities of the Future
Project Farma will be in attendance at this year’s ISPE Facilities of the Future conference, January 29-30, in San Francisco, CA where we will witness exciting technical presentations, case-studies, and panel discussions from industry and regulatory leaders involved in the planning, building, and approving of the “facilities of the future”.
The 2024 ISPE Facilities of the Future Conference brings together pharmaceutical industry stakeholders, particularly those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.
This conference will explore innovations in facility design and delivery, emerging trends in technologies, manufacturing, and support areas such as laboratories and warehousing. Also included are the ways technology and digital transformation will impact the workforce of the future, and sustainability efforts in both new and legacy pharmaceutical facilities.
Click here to learn more.